Watch the May clinical update from Jo Scott-Jones joined by Dave Maplesden, Pinnacle GP liaison in this 27 minute video. (Written version below.)
Clinical snippets are now available as a podcast too! Search on your favourite podcast platform for The New Zealand General Practice Podcast to listen, or click here to listen on Anchor.
Pharmac and BPAC published guidelines in 2018 regarding management of bleeding in patients on dabigatran or rivaroxaban.
For mild bleeding recommended management is
Reference: Pediatrics 2022;149(5):e2021052061
Reference: Can Fam Physician 2019; 65(1):40-42
New Zealand Formulary states:
The FDA EUA states that men of reproductive potential who are sexually active with individuals of childbearing potential should be counseled to abstain from sex or use a reliable method of contraception for the duration of treatment and for at least 3 months after the last dose of molnupiravir.
A recent BPAC article on OCD recommended Just a Thought as an on-line CBT resource which can be considered while awaiting access to formal psychotherapy for suitable patients.
For more information read the Clinician Welcome Guide and the Clinician getting started guide.
The Ukrainian Special Policy allows Ukrainian-born citizens and residents in New Zealand to sponsor a family who ordinarily reside in the Ukraine. All arrivals will be granted either a two-year working visa or two-year student visa and will have full access to publicly funded health and disability services. As of 16 June 2022, 780 visas have been approved and 213 people have arrived under this policy setting. As part of the policy setting, all health requirements for entering New Zealand have been waived for this visa.
According to 2019 WHO estimates, Ukraine has the fourth highest Tuberculosis (TB) incidence rate among the 53 countries of the WHO European Region. Ukraine has one of the highest burdens of multidrug resistant tuberculosis (MDR-TB) in the world.
The Ministry of Health advises the following: